Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4813
H.R.4813: Matt’s Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced July 29, 2021
- Latest Major Action July 30, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - July 29, 2021
Bill Summary
Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
July 30, 2021 |
Referred to the Subcommittee on Health.
|
July 29, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
July 29, 2021 |
Introduced in the House by Jeff Fortenberry (R-Neb.) |